Hambrecht & Quist Capital Management »

R1 RCM shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of R1 RCM (RCM) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in R1 RCM

Tip: Access up to 7 years of quarterly data

All positions including R1 RCM held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in R1 RCM by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $6.6M 357k 18.45
2023-03-31 $5.4M 357k 15.00
2022-12-31 $2.2M 202k 10.95
2022-09-30 $3.8M 202k 18.53
2022-06-30 $4.2M 202k 20.96

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management